Back

ADEL: A population-based study of clinical outcomes of aldosterone dysregulation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: new treatments and biomarkers in hypertension Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Reimar W Thomsen

Aarhus University, Aarhus (Denmark)

3 More presentations in this session

Presentation thumbnail
Benefit-harm trade-offs of intensive blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of six pivotal randomized controlled trials.
Doctor X. Guo (Shenyang, CN)
Slides Video
Presentation thumbnail
Duration of blood pressure treatment and risk of major cardiovascular events
Professor K. Rahimi (Oxford, GB)
Slides Video
Presentation thumbnail
Sacubitril/Allisartan in hyperuricemia
Doctor W. Zhang (Shanghai, CN)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: new treatments and biomarkers in hypertension
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Systolic plood pressure response to ASi BI 690517 with and without empagliflozin in CKD
thumbnail
Congress Presentation
Ten-year outcomes in patients with hypertension and primary hyperaldosteronism undergoing surgical adrenalectomy versus medical therapy: data from the multinational collaborative network TriNetX
thumbnail
Congress Presentation
Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources